Type 1 Diabetes, Neuropathy, Retinopathy
Conditions
Keywords
Confocal microscopy, Cornea, Neuropathy, Detection, Diabetes
Brief summary
The overall aim of this study is to confirm the utility of corneal confocal microscopy (CCM) as a new technique to rapidly and non-invasively assess diabetic neuropathy (DN) in children. This study will be divided into two phases: Phase 1 will be a cross-sectional study of children with type 1 diabetes and normal controls, while phase 2 will be a longitudinal assessment of a subgroup of children with type 1 diabetes recruited during Phase 1.
Detailed description
In phase 1: To compare corneal nerve density (CND), length (CNL), and branching (CBD) by CCM between 1. children with type 1 diabetes for 5 years or more to children without diabetes; 2. children with type 1 diabetes with and without evidence of diabetic neuropathy; 3. to examine the relationship between CND, CNL & CBD and known risk factors of diabetic neuropathy In phase 2: 1. to examine for changes in corneal nerve morphology two years after the initial CCM exam. 2. to describe the evolution of diabetic neuropathy based on clinical symptoms, neurological deficits, and other tests of nerve dysfunction. 3. to assess if changes in corneal nerve morphology correlate with changes in nerve conduction velocity and autonomic testing. 4. To examine the risk factors associated with progression of diabetic neuropathy in our pediatric population.
Interventions
PROCEDURECorneal Confocal Microscopy
Close-up pictures of the front part of the eye (the cornea)
PROCEDURENerve Conduction Studies
The following assessments will be made: a) amplitude of nerve action potential (μV) and conduction velocity (m/s) of the sural sensory nerve by antidromic stimulation; b) motor nerve conduction velocity (m/s), maximum M-wave amplitude (mV) and motor nerve distal latency (ms) of the peroneal motor nerve; and c) tibial nerve conduction study will also be obtained if tolerated.
PROCEDUREQuantitative sensory testing
Standardized vibratory and thermal stimulation levels applied to the subject's non-dominant big toe.
PROCEDURENeuropathy Symptom Score
A list of 18 motor, sensory and autonomic symptoms encountered in a diabetic patients with neuropathy obtained by interview.
PROCEDUREClinical nerve examination
Summated score of the lower extremities. Neurological examination assessing muscle strength, knee and ankle reflexes, sensation in the great toes will be evaluated for light touch-pressure, temperature, pin-prick, vibratory sense and joint position sense.
Sponsors
Juvenile Diabetes Research Foundation
University of Calgary
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
Yes
Inclusion criteria
* CASES: Children with Type 1 Diabetes 8 to 18 years old followed at the Alberta Children's Hospital Diabetes Clinic with a duration of diabetes of at least 5 years. * CONTROLS: Healthy children aged 8 to 18 years.
Exclusion criteria
* Patients with known history of corneal abnormality, trauma, or surgery * Any other cause of neuropathy * Individuals with uncontrolled hypothyroidism * Individuals with celiac disease * Other serious chronic illnesses besides diabetes * Inability to cooperate with testing * Families unwilling to provide written informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The utility of corneal confocal microscopy to assess diabetic neuropathy in children. | 2 years | To confirm the utility of corneal confocal microscopy (CCM) as a new technique to rapidly assess diabetic neuropathy (DN) in children. This non-invasive eye imaging method may be a superior alternative to traditional nerve conduction studies. This study will be divided into two phases: Phase 1 will be a cross-sectional study of children with Type 1 Diabetes (T1D) and normal controls, while phase 2 will be a longitudinal assessment of a subgroup of T1D children recruited during Phase 1. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Corneal nerve density (CND) by CCM | Single time point | To compare corneal nerve density (CND) between 1. children with T1D for 5 years or more to children without diabetes; 2. children with T1D with and without evidence of DN; 3. to examine the relationship between CND, CNL & CBD and known risk factors of DN |
| Changes in corneal nerve morphology two years after the initial CCM exam. | 2 years | In phase 2 : 1) to examine for changes in corneal nerve morphology two years after the initial CCM exam. 2\) to describe the evolution of DN in based on clinical symptoms, neurological deficits, and other tests of nerve dysfunction. 3\) to assess if changes in corneal nerve morphology correlate with changes in nerve conduction velocity and autonomic testing. 4) To examine the risk factors associated with progression of DN in our pediatric population. |
| Corneal nerve length (CNL) by CCM. | Single time point | To compare corneal nerve length (CNL), by CCM between 1. children with T1D for 5 years or more to children without diabetes; 2. children with T1D with and without evidence of DN; 3. to examine the relationship between CND, CNL & CBD and known risk factors of DN |
| Corneal nerve branching density (CBD) by CCM | Single time point | To compare corneal nerve branching density (CBD) by CCM between 1. children with T1D for 5 years or more to children without diabetes; 2. children with T1D with and without evidence of DN; 3. to examine the relationship between CND, CNL & CBD and known risk factors of DN |
Countries
Canada
Outcome results
None listed